186 related articles for article (PubMed ID: 36372010)
1. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis.
Tang X; Zhang H; Cui Y; Wang L; Wang Z; Zhang Y; Huo J; Cai J; Rinaldi G; Bhagavathula AS; Xiaopeng Y
Pharmacol Res; 2020 Oct; 160():105182. PubMed ID: 32890740
[TBL] [Abstract][Full Text] [Related]
3. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM
J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
5. Exogenous hormone therapy and non-melanoma skin cancer (keratinocyte carcinoma) risk in women: a systematic review and meta-analysis.
Li L; Pei B; Feng Y
BMC Cancer; 2023 Oct; 23(1):946. PubMed ID: 37803321
[TBL] [Abstract][Full Text] [Related]
6. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
8. Skin cancer risk of menopausal hormone therapy in a Korean cohort.
Yuk JS; Lee SK; Uh JA; Seo YS; Kim M; Kim MS
Sci Rep; 2023 Jun; 13(1):10572. PubMed ID: 37386069
[TBL] [Abstract][Full Text] [Related]
9. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health.
Botteri E; Xu Z; Støer NC; Mishra GD
Maturitas; 2022 Jun; 160():1-3. PubMed ID: 35550702
[TBL] [Abstract][Full Text] [Related]
11. The relationship between menopausal hormone therapy and keratinocyte carcinoma: A review.
Suresh R; Twigg A; Murase JE
Int J Womens Dermatol; 2019 Feb; 5(1):8-13. PubMed ID: 30809572
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
13. Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies.
Jang YC; Leung CY; Huang HL
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):114-122. PubMed ID: 36306390
[TBL] [Abstract][Full Text] [Related]
14. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis.
Benkhadra K; Mohammed K; Al Nofal A; Carranza Leon BG; Alahdab F; Faubion S; Montori VM; Abu Dabrh AM; Zúñiga Hernández JA; Prokop LJ; Murad MH
J Clin Endocrinol Metab; 2015 Nov; 100(11):4021-8. PubMed ID: 26544652
[TBL] [Abstract][Full Text] [Related]
15. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
16. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma.
Sun H; Li Y; Zeng F; Meng Y; Du S; Deng G
Int J Dermatol; 2022 Nov; 61(11):1397-1404. PubMed ID: 35726477
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
[TBL] [Abstract][Full Text] [Related]
18. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
